Remdesivir In Adults With Severe Covid 19 A Randomised Double Blind Placebo Controlled Multicentre Trial The Lancet
Compassionate Remdesivir Treatment Of Severe Covid 19 Pneumonia In Intensive Care Unit Icu And Non Icu Patients Clinical Outcome And Differences In Post Treatment Hospitalisation Status Sciencedirect
Full Text A Review On Remdesivir A Possible Promising Agent For The Treatment O Dddt
Coronavirus Zydus Cadila Launches Most Affordable Covid 19 Drug Remdesivir In India
Remdesivir Shows Early Clinical Covid 19 Improvement In Phase 3 Trial